Jeffrey Humphrey - Net Worth and Insider Trading

Jeffrey Humphrey Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jeffrey Humphrey owns 3 companies in total, including Constellation Pharmaceuticals Inc (CNST) , Cyteir Therapeutics Inc (CYTT) , and Magenta Therapeutics Inc (MGTA) .

Click here to see the complete history of Jeffrey Humphrey’s form 4 insider trades.

Insider Ownership Summary of Jeffrey Humphrey

Ticker	Comapny	Transaction Date	Type of Owner
CNST	Constellation Pharmaceuticals Inc	2020-07-07	Chief Medical Officer
CYTT	Cyteir Therapeutics Inc	2021-12-15	director
MGTA	Magenta Therapeutics Inc	2021-10-01	Chief Medical Officer

Jeffrey Humphrey Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jeffrey Humphrey Ownership Network

Ownership Network List of Jeffrey Humphrey

No Data

Ownership Network Relation of Jeffrey Humphrey

Jeffrey Humphrey Owned Company Details

What does Constellation Pharmaceuticals Inc do?

Who are the key executives at Constellation Pharmaceuticals Inc?

Jeffrey Humphrey is the Chief Medical Officer of Constellation Pharmaceuticals Inc. Other key executives at Constellation Pharmaceuticals Inc include Chief Financial Officer Emma Reeve , 10 percent owner Column Group L P , and See Remarks Karen Valentine .

Constellation Pharmaceuticals Inc (CNST) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Constellation Pharmaceuticals Inc (CNST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Constellation Pharmaceuticals Inc (CNST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Constellation Pharmaceuticals Inc (CNST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Constellation Pharmaceuticals Inc Insider Transactions

No Available Data

What does Cyteir Therapeutics Inc do?

Who are the key executives at Cyteir Therapeutics Inc?

Jeffrey Humphrey is the director of Cyteir Therapeutics Inc. Other key executives at Cyteir Therapeutics Inc include 10 percent owner Novo Holdings A/s , General Counsel Adam M Veness , and 10 percent owner Droia Invest Ii Scsp .

Cyteir Therapeutics Inc (CYTT) Insider Trades Summary

Over the past 18 months, Jeffrey Humphrey made no insider transaction in Cyteir Therapeutics Inc (CYTT). Other recent insider transactions involving Cyteir Therapeutics Inc (CYTT) include a net sale of 418,277 shares made by Novo Holdings A/s , and a net purchase of 170,589 shares made by Braden Michael Leonard .

In summary, during the past 3 months, insiders sold 0 shares of Cyteir Therapeutics Inc (CYTT) in total and bought 170,589 shares, with a net purchase of 170,589 shares. During the past 18 months, 418,277 shares of Cyteir Therapeutics Inc (CYTT) were sold and 170,589 shares were bought by its insiders, resulting in a net sale of 247,688 shares.

Cyteir Therapeutics Inc (CYTT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cyteir Therapeutics Inc Insider Transactions

No Available Data

What does Magenta Therapeutics Inc do?

Who are the key executives at Magenta Therapeutics Inc?

Jeffrey Humphrey is the Chief Medical Officer of Magenta Therapeutics Inc. Other key executives at Magenta Therapeutics Inc include director & 10 percent owner Peter Evan Harwin , director & 10 percent owner Tomas Kiselak , and director & 10 percent owner Fairmount Funds Management Llc .

Magenta Therapeutics Inc (MGTA) Insider Trades Summary

Over the past 18 months, Jeffrey Humphrey made no insider transaction in Magenta Therapeutics Inc (MGTA). Other recent insider transactions involving Magenta Therapeutics Inc (MGTA) include a net sale of 3,700,000 shares made by Third Rock Ventures Iv, L.p. ,

In summary, during the past 3 months, insiders sold 0 shares of Magenta Therapeutics Inc (MGTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,700,000 shares of Magenta Therapeutics Inc (MGTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,700,000 shares.

Magenta Therapeutics Inc (MGTA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Magenta Therapeutics Inc Insider Transactions

No Available Data

Jeffrey Humphrey Mailing Address

Above is the net worth, insider trading, and ownership report for Jeffrey Humphrey. You might contact Jeffrey Humphrey via mailing address: C/o Constellation Pharmaceuticals, Inc., 215 First Street, Suite 200, Cambridge Ma 02142.

Discussions on Jeffrey Humphrey

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.